Engineers Gate Manager’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5M | Sell |
218,884
-13,663
| -6% | -$1.13M | 0.22% | 110 |
|
|
2025
Q4 | $19.8M | Sell |
232,547
-102,151
| -31% | -$8.38M | 0.24% | 86 |
|
|
2025
Q3 | $26M | Buy |
334,698
+168,826
| +102% | +$13.2M | 0.3% | 58 |
|
|
2025
Q2 | $13M | Buy |
165,872
+111,209
| +203% | +$8.29M | 0.16% | 164 |
|
|
2025
Q1 | $3.96M | Buy |
+54,663
| New | +$3.91M | 0.07% | 416 |
|
|
2024
Q4 | – | Sell |
-58,009
| Closed | -$3.83M | – | 2327 |
|
|
2024
Q3 | $3.83M | Buy |
+58,009
| New | +$4.21M | 0.07% | 360 |
|
|
2024
Q1 | – | Sell |
-22,534
| Closed | -$1.72M | – | 2021 |
|
|
2023
Q4 | $1.72M | Sell |
22,534
-193,279
| -90% | -$13.4M | 0.05% | 530 |
|
|
2023
Q3 | $15M | Buy |
215,813
+193,945
| +887% | +$15.6M | 0.55% | 6 |
|
|
2023
Q2 | $2.06M | Buy |
21,868
+1,561
| +8% | +$136K | 0.08% | 347 |
|
|
2023
Q1 | $1.68M | Sell |
20,307
-8,011
| -28% | -$630K | 0.07% | 373 |
|
|
2022
Q4 | $2.11M | Sell |
28,318
-102,145
| -78% | -$7.87M | 0.13% | 175 |
|
|
2022
Q3 | $10.8M | Buy |
130,463
+117,519
| +908% | +$11.3M | 0.67% | 5 |
|
|
2022
Q2 | $1.23M | Buy |
12,944
+9,252
| +251% | +$958K | 0.05% | 577 |
|
|
2022
Q1 | $435K | Buy |
3,692
+755
| +26% | +$84.7K | 0.02% | 1142 |
|
|
2021
Q4 | $380K | Sell |
2,937
-4,737
| -62% | -$553K | 0.02% | 1246 |
|
|
2021
Q3 | $869K | Sell |
7,674
-18,410
| -71% | -$2.1M | 0.05% | 560 |
|
|
2021
Q2 | $2.7M | Buy |
+26,084
| New | +$2.46M | 0.17% | 115 |
|
|
2021
Q1 | – | Sell |
-3,780
| Closed | -$345K | – | 1892 |
|
|
2020
Q4 | $345K | Sell |
3,780
-4,077
| -52% | -$338K | 0.02% | 1207 |
|
|
2020
Q3 | $627K | Sell |
7,857
-30,170
| -79% | -$2.35M | 0.03% | 865 |
|
|
2020
Q2 | $2.63M | Buy |
38,027
+17,135
| +82% | +$1.22M | 0.13% | 187 |
|
|
2020
Q1 | $1.31M | Sell |
20,892
-75,813
| -78% | -$5.47M | 0.09% | 308 |
|
|
2019
Q4 | $7.52M | Buy |
96,705
+52,350
| +118% | +$4.09M | 0.33% | 25 |
|
|
2019
Q3 | $3.25M | Sell |
44,355
-21,375
| -33% | -$1.5M | 0.17% | 183 |
|
|
2019
Q2 | $4.05M | Buy |
+65,730
| New | +$3.97M | 0.22% | 119 |
|
|
2018
Q1 | – | Sell |
-14,154
| Closed | -$532K | – | 838 |
|
|
2017
Q4 | $532K | Buy |
+14,154
| New | +$519K | 0.04% | 583 |
|
|
2017
Q3 | – | Sell |
-124,620
| Closed | -$4.91M | – | 725 |
|
|
2017
Q2 | $4.91M | Buy |
124,620
+83,007
| +199% | +$3.03M | 0.44% | 35 |
|
|
2017
Q1 | $1.3M | Buy |
+41,613
| New | +$1.3M | 0.13% | 287 |
|
|
2016
Q3 | – | Sell |
-176,625
| Closed | -$5.87M | – | 646 |
|
|
2016
Q2 | $5.87M | Buy |
176,625
+9,960
| +6% | +$341K | 0.42% | 21 |
|
|
2016
Q1 | $4.9M | Buy |
166,665
+139,065
| +504% | +$3.84M | 0.38% | 69 |
|
|
2015
Q4 | $727K | Buy |
+27,600
| New | +$717K | 0.05% | 450 |
|
|
2015
Q3 | – | Sell |
-66,456
| Closed | -$1.58M | – | 741 |
|
|
2015
Q2 | $1.58M | Buy |
66,456
+55,056
| +483% | +$1.24M | 0.15% | 205 |
|
|
2015
Q1 | $271K | Sell |
11,400
-7,926
| -41% | -$178K | 0.04% | 740 |
|
|
2014
Q4 | $410K | Buy |
+19,326
| New | +$388K | 0.12% | 320 |
|
Other funds holding EW
VCM
VPM
Engineers Gate Manager's EW Position: Q1 2026 in Review
Engineers Gate Manager reduced its Edwards Lifesciences (EW) stake by 5.9% in Q1 2026, selling an estimated $1.13M and leaving 218,884 shares worth $17.5M. The position accounts for 0.22% of the portfolio, ranked #110.
Engineers Gate Manager first reported a position in EW in Q4 2014 and has held it in 33 quarters since. The position peaked at $26M in Q3 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Engineers Gate Manager held 218,884 shares of Edwards Lifesciences worth $17.5M as of Q1 2026.
- Engineers Gate Manager sold 13,663 Edwards Lifesciences shares in Q1 2026, an estimated $1.13M.
- Edwards Lifesciences made up 0.22% of Engineers Gate Manager's portfolio in Q1 2026, its #110 holding.
- Engineers Gate Manager first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 33 quarters since.
- Engineers Gate Manager's Edwards Lifesciences position peaked at $26M in Q3 2025.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.